Table of Contents

company-logo

Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research in Europe, Asia, and the United States. It offers in-vitro diagnostic reagents for clinical chemistry analyzers. The company's products include the gentian calprotectin immunoassay, a turbidimetric assay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Cystatin C, a superior GFR marker for the diagnosis and therapeutic control of renal function; NT-proBNP Immunoassay for diagnosis, monitoring, and assessment of severity in individuals suspected of having congestive heart failure; and Canine c-reactive protein (CRP) immunoassay, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine CRP in dog plasma and serum. It also provides turbidimetric SARS-CoV-2 total antibody immunoassay, a quantitative antibody test for detecting antibodies targeting the S1-subunit. The company was incorporated in 2001 and is headquartered in Moss, Norway.

Gentian Diagnostics Dividend Announcement

• Gentian Diagnostics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Gentian Diagnostics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Gentian Diagnostics Dividend History

Gentian Diagnostics Dividend Yield

Gentian Diagnostics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Gentian Diagnostics stock? Use our calculator to estimate your expected dividend yield:

Gentian Diagnostics Financial Ratios

P/E ratio243.12
PEG ratio-7.90
P/B ratio3.78
ROE1.63%
Payout ratio0.00%
Current ratio7.04
Quick ratio5.01
Cash Ratio4.48

Gentian Diagnostics Dividend FAQ

Does Gentian Diagnostics stock pay dividends?
Gentian Diagnostics does not currently pay dividends to its shareholders.
Has Gentian Diagnostics ever paid a dividend?
No, Gentian Diagnostics has no a history of paying dividends to its shareholders. Gentian Diagnostics is not known for its dividend payments.
Why doesn't Gentian Diagnostics pay dividends?
There are several potential reasons why Gentian Diagnostics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Gentian Diagnostics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Gentian Diagnostics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Gentian Diagnostics a dividend aristocrat?
Gentian Diagnostics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Gentian Diagnostics a dividend king?
Gentian Diagnostics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Gentian Diagnostics a dividend stock?
No, Gentian Diagnostics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Gentian Diagnostics stocks?
To buy Gentian Diagnostics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Gentian Diagnostics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.